Cargando…

Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease

The present study was designed to investigate the role of circulating miRNA-21 (miR-21) in vascular restenosis of lower extremity arterial occlusive disease (LEAOD) patients after interventional therapy. A total of 412 LEAOD patients were enrolled randomly in the present study. According to computed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bo, Yao, Ye, Sun, Qing-Feng, Liu, Si-qi, Jing, Bao, Yuan, Chao, Liu, Xin-Yu, Jiao, Tong, Li, Hao-cheng, Wang, Hai-Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484015/ https://www.ncbi.nlm.nih.gov/pubmed/28250135 http://dx.doi.org/10.1042/BSR20160502

Ejemplares similares

MircoRNA-26a与肿瘤
Publicado: (2017)

Dexmedetomidine suppresses the development of abdominal aortic aneurysm by downregulating the mircoRNA-21/PDCD 4 axis
por: Yu, Qi, et al.
Publicado: (2021)

Free circulating mircoRNAs support the diagnosis of invasive aspergillosis in patients with hematologic malignancies and neutropenia
por: Tolnai, Emese, et al.
Publicado: (2020)

A novel diagnostic signature based on three circulating exosomal mircoRNAs for chronic obstructive pulmonary disease
por: Shen, Yahui, et al.
Publicado: (2021)

MircoRNA‐1275 promotes proliferation, invasion and migration of glioma cells via SERPINE1
por: Wu, Dong‐Mei, et al.
Publicado: (2018)

MircoRNA in Extracellular Vesicles from Patients with Pulmonary Arterial Hypertension Alters Endothelial Angiogenic Response
por: Khandagale, Avinash, et al.
Publicado: (2022)

MircoRNA-145 promotes activation of hepatic stellate cells via targeting krüppel-like factor 4
por: Men, Ruoting, et al.
Publicado: (2017)

Upregulation of MircoRNA-370 Induces Proliferation in Human Prostate Cancer Cells by Downregulating the Transcription Factor FOXO1
por: Wu, Ziqing, et al.
Publicado: (2012)

Author Correction: MircoRNA-145 promotes activation of hepatic stellate cells via targeting krüppel-like factor 4
por: Men, Ruoting, et al.
Publicado: (2023)

Inhibition of mircoRNA-34a Enhances Survival of Human Bone Marrow Mesenchymal Stromal/Stem Cells Under Oxidative Stress
por: Liu, Yang, et al.
Publicado: (2018)

MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer
por: Yang, Lihua, et al.
Publicado: (2015)

Administration of mircoRNA‐135b‐reinforced exosomes derived from MSCs ameliorates glucocorticoid‐induced osteonecrosis of femoral head (ONFH) in rats
por: Zhang, Xiang, et al.
Publicado: (2020)

Could Down-Regulation of Muscle-Specific MircoRNAs Provoke Functional Dyspepsia in Helicobacter pylori-Infected Stomach? (Gastroenterology 2011;140:189-198)
por: Lee, Byung Hwan, et al.
Publicado: (2011)

Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression
por: Guo, Shanqi, et al.
Publicado: (2016)

Diagnostic Value of Circulating microRNAs for In-Stent Restenosis in Patients with Lower Extremity Arterial Occlusive Disease
por: Yuan, Liangxi, et al.
Publicado: (2019)

Retraction Note: MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer
por: Yang, Lihua, et al.
Publicado: (2021)

Overexpression of mircoRNA-137 inhibits cervical cancer cell invasion, migration and epithelial–mesenchymal transition by suppressing the TGF-β/smad pathway via binding to GREM1
por: Miao, Hui, et al.
Publicado: (2019)

Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease
por: Yu, Zhi-Hai, et al.
Publicado: (2017)

Effect of Bang® Pre-Workout Master Blaster® combined with four weeks of resistance training on lean body mass, maximal strength, mircoRNA expression, and serum IGF-1 in men: a randomized, double-blind, placebo-controlled trial
por: Schwarz, Neil A., et al.
Publicado: (2019)

Cerebral collateral circulation as an independent predictor for in-stent restenosis after carotid artery stenting
por: Liu, Luji, et al.
Publicado: (2023)

The performance of irradiated CMS silicon mirco-strip detector modules
por: deBoer, W, et al.
Publicado: (2006)

The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis
por: Yang, Bo, et al.
Publicado: (2023)

Intravascular Ultrasound and Angiographic Predictors of In-Stent Restenosis of Chronic Total Occlusion Lesions
por: Kang, Jeehoon, et al.
Publicado: (2015)

GRIA2/ENPP3 Regulates the Proliferation and Migration of Vascular Smooth Muscle Cells in the Restenosis Process Post-PTA in Lower Extremity Arteries
por: Zhou, Mi, et al.
Publicado: (2021)

Prevalence, predictors, and management for balloon uncrossable or undilatable lesions in patients undergoing percutaneous coronary intervention with in-stent restenosis chronic total occlusion
por: Wang, Yong, et al.
Publicado: (2023)

Differences between Lower Extremity Arterial Occlusion vs. Stenosis and Predictors of Successful Endovascular Interventions
por: Kokkinidis, Damianos G., et al.
Publicado: (2023)

Expression of platelet-derived growth factor in the vascular walls of patients with lower extremity arterial occlusive disease
por: ZHANG, YANG, et al.
Publicado: (2015)

Periadventitial Application of Rapamycin-Loaded Nanoparticles Produces Sustained Inhibition of Vascular Restenosis
por: Shi, Xudong, et al.
Publicado: (2014)

Open and Endovascular Treatment of Trans-Atlantic Inter-Society Consensus II D Aortoiliac Occlusive Lesions: What Determines the Rate of Restenosis?
por: Shen, Chen-Yang, et al.
Publicado: (2015)

ON VASCULAR STENOSIS, RESTENOSIS AND MANNOSE BINDING LECTIN
por: KAHLOW, Barbara Stadler, et al.
Publicado: (2016)

Noncoding RNAs in Vascular Cell Biology and Restenosis
por: Efovi, Denis, et al.
Publicado: (2022)

Knuckle technique guided by intravascular ultrasound for in-stent restenosis occlusion treatment
por: Tasic, Mladen, et al.
Publicado: (2015)

Enabling Angioplasty‐Ready “Smart” Stents to Detect In‐Stent Restenosis and Occlusion
por: Chen, Xing, et al.
Publicado: (2018)

Circulating Biomarkers in Lower Extremity Artery Disease
por: Ziegler, Louise, et al.
Publicado: (2022)

Restenosis After Percutaneous Angioplasty: The Role of Vascular Inflammation
por: Schillinger, Martin, et al.
Publicado: (2005)

In Stent Restenosis Predictors after Carotid Artery Stenting
por: Cosottini, Mirco, et al.
Publicado: (2010)

Clinical impact and predictors of carotid artery in-stent restenosis
por: Wasser, Katrin, et al.
Publicado: (2012)

p21-Activated Kinase 4 Promotes Intimal Hyperplasia and Vascular Smooth Muscle Cells Proliferation during Superficial Femoral Artery Restenosis after Angioplasty
por: Yuan, Liangxi, et al.
Publicado: (2017)

Should embolectomy be performed in late acute lower extremity arterial occlusions?
por: Iyem, Hikmet, et al.
Publicado: (2009)

Simultaneous hybrid revascularization for symptomatic lower extremity arterial occlusive disease
por: JOH, JIN HYUN, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_id13g24kc5cu6kk6rejurj6j63